Pekka Kuukasjarvi
Tampere, Finland
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 11 publications
Ceramide-phospholipid risk score associates with cardiovascular events and is lowered by atorvastatin, simvastatin and anti-PCSK9 treatments.
Journal: Journal of cardiovascular pharmacology
Published: July 10, 2026
Associations of Polymorphisms in the Peroxisome Proliferator-Activated Receptor Gamma Coactivator-1 Alpha Gene With Subsequent Coronary Heart Disease: An Individual-Level Meta-Analysis.
Journal: Frontiers in physiology
Published: March 31, 2022
Genome-wide analysis identifies novel susceptibility loci for myocardial infarction.
Journal: European heart journal
Published: May 05, 2020
Association of Chromosome 9p21 With Subsequent Coronary Heart Disease Events.
Journal: Circulation. Genomic and precision medicine
Published: March 22, 2019
Subsequent Event Risk in Individuals With Established Coronary Heart Disease.
Journal: Circulation. Genomic and precision medicine
Published: March 22, 2019
Model selection for metabolomics: predicting diagnosis of coronary artery disease using automated machine learning.
Journal: Bioinformatics (Oxford, England)
Published: March 18, 2019
Biomarker Glycoprotein Acetyls Is Associated With the Risk of a Wide Spectrum of Incident Diseases and Stratifies Mortality Risk in Angiography Patients.
Journal: Circulation. Genomic and precision medicine
Published: December 21, 2018
Genome-wide association study pinpoints a new functional apolipoprotein B variant influencing oxidized low-density lipoprotein levels but not cardiovascular events: AtheroRemo Consortium.
Journal: Circulation. Cardiovascular genetics
Published: December 19, 2012
High-throughput quantification of circulating metabolites improves prediction of subclinical atherosclerosis.
Journal: European heart journal
Published: March 28, 2012
Showing 1-11 of 11
Last Updated: 09/26/2026